ArticleNPJ precision oncology2025

A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma.

Jun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.